Navigation Links
Loyola Cancer Center receives Outstanding Achievement Award

MAYWOOD, Ill. -- Loyola University Health System's Cardinal Bernardin Cancer Center has received an Outstanding Achievement Award from the Commission on Cancer of the American College of Surgeons.

The award is given to a select group of centers that receive the highest rating in each of seven standards. The centers were surveyed in 2011.

The seven standards represent six areas of cancer program activity: cancer committee leadership, cancer data management, clinical management, research, community outreach and quality improvement. Centers undergo on-site evaluation by physician surveyors. To qualify for the Outstanding Achievement Award, a center also must be in compliance with 29 other program standards.

Nationwide, 106 programs, or 22 percent of the total cancer centers, received Outstanding Achievement Awards. In the Chicago area, only three centers besides Loyola received the award.

Receiving care at a center accredited by the Commission on Cancer ensures that a patient will have access to the full range of quality cancer care close to home.

The Commission on Cancer, established in 1922 by the American College of Surgeons, is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education and monitoring of comprehensive quality care. Its membership includes Fellows of the American College of Surgeons and representatives of 47 national organizations that reflect the full spectrum of cancer care.


Contact: Jim Ritter
Loyola University Health System

Page: 1

Related medicine news :

1. Loyola nurse practitioner reduces unnecessary emergency department visits
2. Doctor to the worlds poor to speak at Loyola
3. Loyolas on-site cardiology team dramatically improves care for heart attack patients
4. Loyola physician helps develop national guidelines for osteoporosis
5. Louisiana's First DNP Program Kicks Off Classes at Loyola University New Orleans
6. Chicago Trial Attorney Inducted as Loyola University Chicago School of Law's First Cooney & Conway Chair in Advocacy
7. Loyola among worlds top centers in pathology competition
8. Kinase test may yield big gains for drug-resistant cancers
9. Herbal Remedy Ingredient Tied to Cancer, Kidney Failure
10. Parents of Kids With Cancer No More Likely to Break Up
11. Huntingtons Disease Linked to Reduced Cancer Risk in Study
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: